Pharmalab

Executive Summary

Pharmalab Enterprises, Inc. is a private label contract manufacturer specializing in liquid and semi-solid over-the-counter (OTC) medications, dietary supplements, and cosmetics. Founded in 2004 and based in St. Paul, Minnesota, the company is FDA-registered and holds key NSF GMP certifications for dietary supplements and OTC drugs. Pharmalab provides full turn-key solutions, including formulation, manufacturing, filling, and packaging, with a focus on establishing long-term customer relationships through competitive pricing and personalized bilingual support. The company serves a diverse client base, offering flexibility and quality assurance that align with evolving regulatory standards. As a private entity with no disclosed financials, Pharmalab's growth trajectory is driven by its ability to secure new contracts and expand its manufacturing capabilities. The company's established certifications and reputation position it well to benefit from increasing demand for OTC and supplement products, particularly as consumer health awareness rises. Potential catalysts include capacity expansion to meet growing order volumes, new client partnerships with larger retailers or brands, and possible acquisitions to broaden its product offerings or geographic reach. While concrete near-term events are not publicly available, the company's stable operational foundation suggests a moderate conviction score of 65. Upcoming catalysts could include securing a new major contract or completing a facility upgrade, with expected timelines in the second half of 2026.

Upcoming Catalysts (preview)

• Q3 2026New major contract with a national retailer or brand60% success
• Q4 2026Completion of manufacturing capacity expansion70% success
• TBDAcquisition or partnership to enter new product categories50% success